ACE2 and infection: Notably, changes in ACE2 that increased infection efficiencies in the absence of TMPRSS2 (i.e., N322A and 7×) were associated with reduced sensitivity to inhibition by Camostat in the case of HU-1 and BA.5 S (Fig. 5C).